No definition available.
Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
AB1_VIRAL_SKIN_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1511 |
4. Check minimum number of eventsNone |
1511 |
5. Include endpointsNone |
1511 |
6. Filter based on genotype QC (FinnGen only) |
1511 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Viral infections characterized by skin and mucous membrane lesions
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 28589 | 13897 | 14649 |
| Only index persons | 18938 | 9296 | 9642 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.40 | 0.40 | 0.41 |
| Only index persons | 0.36 | 0.34 | 0.37 |
| Median age at first event (years) | |||
| Whole population | 2.18 | 2.31 | 1.97 |
| Only index persons | 2.76 | 3.27 | 2.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1511 | 934 | 577 |
| Unadjusted period prevalence (%) | 0.29 | 0.32 | 0.25 |
| Median age at first event (years) | 9.76 | 9.04 | 10.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1337
- Matched controls
- 13367
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
05710
ICD-8 Finland
Other viral exanthem, Exanthema subitum (sixth disease)
+∞
254.5
236
*
B08.1
ICD-10 Finland
Molluscum contagiosum
113.5
240.3
257
28
B08.4
ICD-10 Finland
Enteroviral vesicular stomatitis with exanthem
59.9
177.5
208
41
B09
ICD-10 Finland
Unspecified viral infection characterized by skin and mucous membrane lesions
243.7
130.4
132
6
0578A
ICD-9 Finland
Other viral exanthemata, Other specified viral exanthemata[EXANTHEMA SUBITUM]
+∞
120.7
114
*
B08.8
ICD-10 Finland
Other specified viral infections characterized by skin and mucous membrane lesions
+∞
58.8
56
*
0579X
ICD-9 Finland
Other viral exanthemata, Viral exanthem, unspecified
+∞
58.8
56
*
B08.2
ICD-10 Finland
Exanthema subitum [sixth disease]
72.0
54.6
62
9
05799
ICD-8 Finland
Other viral exanthem, Unspecified
+∞
51.4
49
*
B08.3
ICD-10 Finland
Erythema infectiosum [fifth disease]
110.3
49.1
53
5
H03.1*B08.1
ICD-10 Finland
Involvement of eyelid in molluscum contagiosum
+∞
44.0
42
*
B08.5
ICD-10 Finland
Enteroviral vesicular pharyngitis
31.7
30.5
40
13
R50.9
ICD-10 Finland
Fever, unspecified
2.4
26.2
252
1177
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
25.4
124
376
05797
ICD-8 Finland
Other viral exanthem, Suspecta
+∞
24.0
23
*
H02AB06
ATC
prednisolone; systemic
1.8
21.8
511
3393
127
Kela drug reimbursment
Transplant complication
9.0
19.9
42
48
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
7.7
19.5
45
60
B07.9
ICD-10 Finland
Verruca simplex
5.4
19.1
58
112
L04AD01
ATC
ciclosporin; systemic
6.7
17.0
43
66
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
16.2
193
982
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
3.7
15.9
71
201
J01DB01
ATC
cefalexin; oral
1.7
15.7
1033
8884
J01DA01
ATC
[U] cefalexin; systemic
1.6
15.7
718
5602
0578X
ICD-9 Finland
Other viral exanthemata, Other specified viral exanthemata[EXANTHEMA VIROGENA ALIA]
+∞
15.6
15
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
15.5
402
2690
J01FA10
ATC
azithromycin; systemic
1.6
14.8
820
6670
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
14.4
220
1233
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
14.2
84
295
D07AB08
ATC
desonide; topical
2.2
13.7
148
722
H02AB09
ATC
hydrocortisone; systemic
3.8
13.4
56
151
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.1
13.3
167
867
J05AB01
ATC
aciclovir; systemic
1.9
13.1
224
1305
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.0
12.8
73
249
L04AX01
ATC
azathioprine; systemic
3.0
12.8
75
262
E0000UV
ATC
NA
1.6
12.8
516
3834
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
12.7
740
5985
ZX120
NOMESCO Finland
Intravenous
2.4
12.7
111
486
D07AC01
ATC
betamethasone; topical
1.7
12.6
345
2321
A02BC02
ATC
pantoprazole; systemic
1.5
12.3
600
4650
L04AA06
ATC
mycophenolic acid; systemic
5.8
12.3
34
60
N02AX02
ATC
tramadol; systemic, rectal
1.6
12.0
366
2531
J05AB11
ATC
valaciclovir; oral
2.1
12.0
138
690
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
4.0
11.8
47
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
11.8
204
1189
L04AA01
ATC
[U] ciclosporin; systemic
9.0
11.8
24
27
137
Kela drug reimbursment
Uraemia requiring dialysis
9.3
11.5
23
25
J01CA04
ATC
amoxicillin; systemic
1.7
11.1
1118
10095
J01AA02
ATC
doxycycline; systemic
1.5
11.0
766
6350
N02BE01
ATC
paracetamol; systemic, rectal
1.5
11.0
942
8164
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.1
11.0
21
21
B02.9
ICD-10 Finland
Zoster without complication
4.0
10.9
43
111
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
3.3
10.8
53
164
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
10.7
221
1365
A02BC01
ATC
omeprazole; systemic
1.7
10.6
249
1598
B34.9
ICD-10 Finland
Viral infection, unspecified
2.6
10.2
72
283
Z94.0
ICD-10 Finland
Kidney transplant status
6.3
10.2
26
42
R06AE07
ATC
cetirizine; oral
1.5
10.2
548
4282
C03CA01
ATC
furosemide; systemic
1.9
10.1
146
799
M01AE02
ATC
naproxen; oral, rectal
1.4
9.9
689
5658
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
9.9
135
725
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
9.8
103
495
Z49.2
ICD-10 Finland
Other dialysis
8.8
9.8
20
23
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
9.7
61
223
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
9.7
193
1174
J01FF01
ATC
clindamycin; systemic
1.6
9.5
268
1798
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.0
9.5
120
623
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.4
445
3368
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.9
9.4
133
722
TQW00
NOMESCO Finland
Removal of molluscum
+∞
9.4
9
*
B05DA
ATC
Isotonic solutions
9.6
9.3
18
19
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.9
9.1
24
41
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.9
333
2392
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.2
8.8
87
409
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
9.5
8.8
17
18
A12AA04
ATC
calcium carbonate; oral
5.4
8.8
25
47
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.4
8.7
30
69
L30.3
ICD-10 Finland
Infective dermatitis
3.3
8.7
41
125
L03AA02
ATC
filgrastim; parenteral
4.7
8.4
27
58
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
8.4
184
1153
E000001
ATC
NA
1.6
8.3
268
1855
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.5
8.3
64
266
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.3
234
1568
7803A
ICD-9 Finland
General symptoms, Convulsions
3.8
8.3
33
88
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.6
8.2
27
60
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.2
236
1591
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
8.2
300
2142
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.6
8.1
35
100
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.1
8.0
24
48
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.0
297
2122
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
8.0
193
1240
H02AB04
ATC
methylprednisolone; systemic
1.8
8.0
129
733
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.9
666
5572
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.6
7.9
19
29
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
7.9
556
4508
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
7.8
165
1021
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.4
7.8
27
63
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
7.8
38
119
4451
FHL
Guitar cutting
2.1
7.8
84
410
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
9.5
7.8
15
16
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
7.8
311
2258
A11CC03
ATC
alfacalcidol; systemic
3.9
7.8
30
78
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.1
7.7
40
132
J04.0
ICD-10 Finland
Acute laryngitis
2.2
7.7
76
358
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
7.6
151
918
K06.18
ICD-10 Finland
Another gingival hyperplasia
8.9
7.5
15
17
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
7.5
118
666
602
Kela drug reimbursment
Children's severe malnutrition
4.2
7.5
27
66
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
7.5
105
571
B01.9
ICD-10 Finland
Varicella without complication
6.5
7.4
18
28
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
13.4
7.4
12
9
R01AD08
ATC
fluticasone; nasal
1.5
7.4
315
2318
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.3
78
377
R05
ICPC
Cough
1.5
7.3
278
1993
B05DB
ATC
Hypertonic solutions
9.4
7.3
14
15
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
4.5
7.3
24
54
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
2.6
7.2
50
195
UJF32
NOMESCO Finland
Coloscopy
1.6
7.2
188
1232
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.1
7.2
77
376
XF602
NOMESCO Finland
Bloodpressure monitoring
5.3
7.1
20
38
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
7.1
88
458
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.1
378
2902
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
8.8
7.0
14
16
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.0
283
2057
WX110
NOMESCO Finland
Local anesthesy
1.4
6.9
881
7817
ZXC50
NOMESCO Finland
Cryotherapy
4.4
6.8
23
53
N05CF01
ATC
zopiclone; oral
1.5
6.8
243
1715
SPAT1263
SPAT
Sampling
1.4
6.8
510
4144
B01AB05
ATC
enoxaparin; parenteral
1.5
6.8
214
1467
R03AC02
ATC
salbutamol; inhalant
1.4
6.7
630
5306
J01FA09
ATC
clarithromycin; systemic
1.4
6.7
343
2604
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
6.6
152
962
E000006
ATC
NA
2.0
6.6
76
383
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
6.6
201
1370
6BA02
NOMESCO Finland
NA
7.8
6.6
14
18
C03DA01
ATC
spironolactone; oral
2.2
6.5
64
302
C07AB07
ATC
bisoprolol; oral
1.5
6.5
274
2003
D07AA02
ATC
hydrocortisone; topical
1.5
6.5
204
1401
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
6.5
81
422
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
6.5
85
452
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.3
6.4
30
93
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
6.4
37
131
UDC00
NOMESCO Finland
Ear microscopy
1.9
6.4
84
445
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
6.4
151
966
P01BA02
ATC
hydroxychloroquine; oral
2.0
6.4
72
362
M03BX02
ATC
tizanidine; oral
1.3
6.4
618
5219
D07AC13
ATC
mometasone; topical
1.5
6.3
273
2006
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
6.0
6.3
16
27
ZX112
NOMESCO Finland
Subcutaneous
3.9
6.3
24
63
A02BC05
ATC
esomeprazole; systemic
1.4
6.3
336
2573
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
+∞
6.3
6
*
05700
ICD-8 Finland
Other viral exanthem, Erythema infectiosum (fifth disease)
+∞
6.3
6
*
J02AC01
ATC
fluconazole; systemic
1.4
6.2
414
3291
G44.2
ICD-10 Finland
Tension-type headache
1.6
6.2
145
925
R01AD09
ATC
mometasone; nasal
1.3
6.1
521
4307
Z94.4
ICD-10 Finland
Liver transplant status
10.1
6.0
11
11
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.2
6.0
55
252
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
92
233
4.14
32.83
9.2
7.2
299.1
866.6
iu/ml
0.52
14
32
886
6945
1.67
20.19
13.6
9.0
4.0
3.9
e9/l
1.07
786
6020
806
6170
1.66
20.12
10.3
6.4
30.3
31.2
%
1.45
769
5841
557
3895
1.68
19.64
7.1
5.2
37.0
37.1
g/l
0.10
527
3644
446
2940
1.73
19.54
4.6
3.0
0.1
0.4
e6/l
4.58
344
2149
349
2166
1.79
18.74
3.7
2.5
7.1
7.6
e6/l
0.18
318
1883
527
3670
1.67
18.66
5.1
3.2
—
—
—
0
0
180
901
2.13
18.20
5.2
4.6
238.3
254.9
u/l
0.80
175
856
927
7560
1.59
16.22
5.3
3.8
83.1
991.4
e6/l
1.40
14
94
441
3036
1.64
15.81
3.4
2.9
2.4
2.4
mmol/l
0.30
402
2738
241
1422
1.83
15.02
2.2
1.8
—
—
—
0
0
96
402
2.48
14.73
2.0
1.5
1.1
1.2
g/l
0.43
91
382
49
141
3.56
14.64
2.6
2.8
9.0
10.3
%
0.41
28
107
767
6087
1.53
14.42
6.7
5.1
6.2
6.3
mmol/l
1.08
712
5521
93
389
2.48
14.30
2.0
1.5
0.2
0.2
g/l
0.01
87
371
633
4841
1.53
14.01
11.3
7.3
1.2
1.2
mmol/l
0.48
540
4171
237
1426
1.79
13.77
11.7
7.4
1.2
1.2
mmol/l
0.26
227
1339
46
135
3.48
13.36
2.7
2.8
—
—
—
0
0
64
230
2.86
13.28
5.1
3.8
55.9
55.3
%
0.14
64
230
242
1485
1.75
13.10
8.1
5.4
0.8
0.8
mmol/l
0.98
231
1397
63
227
2.85
13.02
4.6
3.6
3.9
4.0
e9/l
0.08
63
227
330
2206
1.63
12.95
4.1
2.5
336.4
4767.6
umol/l
5.95
292
1977
577
4381
1.51
12.92
10.9
7.3
1.2
1.2
mmol/l
0.61
534
4032
416
2961
1.56
12.46
3.4
2.8
24.1
38.6
ng/l
1.11
206
1461
273
1761
1.67
12.26
3.7
2.6
1.1
1.2
e6/l
0.08
151
962
929
7846
1.48
11.80
10.2
6.2
83.5
81.9
u/l
0.27
892
7387
715
5761
1.46
11.46
4.3
3.1
0.0
0.0
estimate
0.80
173
1097
964
8242
1.47
11.20
5.7
3.6
10.2
8.7
mm/h
3.13
915
7704
415
3018
1.52
11.06
3.1
2.6
55.4
55.5
u/l
0.00
391
2807
717
5809
1.45
11.01
4.3
3.1
0.0
0.0
estimate
0.21
173
1096
628
4986
1.44
10.63
8.6
5.6
11.3
13.2
umol/l
1.70
593
4663
709
5768
1.43
10.45
5.9
4.3
0.0
0.0
estimate
0.50
178
1133
258
1704
1.62
10.44
4.1
2.8
2.5
2.7
e6/l
0.13
136
909
43
142
3.09
10.40
2.8
3.0
0.2
0.2
e9/l
0.10
34
108
194
1194
1.72
10.29
8.2
6.4
5.8
5.8
kpa
0.13
188
1158
193
1189
1.71
10.19
8.2
6.4
1.4
1.4
mmol/l
0.02
155
918
350
2500
1.52
10.01
2.6
2.1
176.9
275.7
u/l
1.35
331
2390
250
1658
1.61
9.91
4.2
3.5
861.2
941.6
ng/l
0.17
202
1337
19
36
5.33
9.65
6.6
9.4
—
—
—
0
0
163
975
1.75
9.55
2.2
1.7
—
—
—
0
0
77
356
2.23
9.50
2.4
1.8
—
—
—
0
0
96
490
2.02
9.19
13.9
11.3
1.3
1.1
mg/l
1.67
90
465
51
199
2.62
9.13
2.3
1.7
—
—
—
0
0
1260
11539
1.55
9.12
17.1
11.0
139.5
139.5
mmol/l
0.09
1229
11216
73
336
2.23
9.11
2.0
1.6
88.2
101.5
u/ml
—
9
54
87
431
2.08
9.03
1.7
1.4
—
—
—
0
0
162
987
1.72
8.89
2.3
1.8
—
—
—
0
0
13
18
7.28
8.85
5.9
6.9
—
—
—
0
0
13
18
7.28
8.85
6.8
7.1
—
—
—
0
0
41
145
2.88
8.84
2.9
3.0
638.9
547.4
e6/l
0.54
32
109
536
4240
1.41
8.81
2.0
1.7
—
—
—
0
0
1260
11568
1.54
8.70
17.4
11.0
3.9
3.9
mmol/l
0.94
1229
11201
172
1072
1.68
8.68
8.4
6.2
5.3
5.0
kpa
0.59
167
1040
399
3004
1.45
8.60
4.7
3.3
0.0
0.0
estimate
0.22
169
1115
64
287
2.28
8.51
2.1
1.7
—
—
—
0
0
11
13
8.52
8.47
9.9
9.9
—
—
—
0
0
51
207
2.51
8.45
2.9
2.4
—
—
—
0
0
947
8276
1.39
8.35
3.8
3.0
39.1
36.9
u/l
0.37
908
7919
1327
12359
1.61
8.24
17.3
10.3
20.1
21.1
mg/l
0.55
1094
9266
1126
10146
1.43
8.23
13.4
8.5
94.8
95.4
ml/min/173m2
0.37
936
7955
115
649
1.84
8.19
8.2
5.1
74.2
66.7
ng/l
0.43
104
596
231
1570
1.56
8.17
3.7
2.3
13.6
14.6
umol/l
1.22
217
1465
147
894
1.71
8.11
8.6
6.7
23.9
23.7
mmol/l
0.46
142
847
83
421
2.03
8.11
1.7
1.4
320.5
212.8
u/ml
1.80
52
220
24
64
3.79
8.08
1.1
1.1
—
—
—
0
0
168
1061
1.66
8.05
12.7
10.9
24.6
24.5
mmol/l
0.04
168
1054
151
929
1.69
7.99
3.8
3.0
0.2
0.2
g/l
0.03
145
878
198
1305
1.60
7.99
4.0
2.4
23.1
23.9
%
0.32
173
1163
22
56
3.97
7.89
2.4
3.4
1067.7
809.0
u/ml
0.33
22
56
112
636
1.82
7.82
2.4
1.6
—
—
—
0
0
563
4562
1.37
7.78
3.5
2.4
75.0
71.7
nmol/l
2.39
525
4258
213
1437
1.56
7.77
3.8
2.3
2.5
2.5
g/l
0.06
199
1335
73
360
2.08
7.70
1.5
1.7
128.0
260.0
titre
—
5
8
38
140
2.76
7.64
1.7
1.6
—
—
—
0
0
44
175
2.56
7.62
2.2
1.7
—
—
—
0
0
62
288
2.20
7.61
2.2
1.7
—
—
—
0
0
548
4452
1.36
7.34
4.3
3.0
—
—
—
0
0
42
167
2.56
7.29
1.8
1.4
—
—
—
0
0
162
1041
1.62
7.25
1.6
1.3
289.0
212.5
u/ml
0.33
151
974
30
100
3.04
7.21
1.2
1.1
—
—
—
0
0
30
100
3.04
7.21
1.2
1.1
—
—
—
0
0
15
30
5.04
7.19
4.9
4.8
—
—
—
0
0
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
30
101
3.01
7.10
1.2
1.1
—
—
—
0
0
200
1364
1.54
6.93
2.8
2.5
2.4
2.4
mmol/l
0.01
181
1180
139
872
1.65
6.84
3.3
2.6
—
—
—
0
0
329
2481
1.42
6.84
2.4
2.2
1.6
1.1
mg/l
0.39
245
1784
35
133
2.67
6.67
2.6
2.6
693.5
764.0
e6/l
—
10
35
48
214
2.28
6.54
1.3
1.2
1.0
1.4
u/ml
—
5
17
54
253
2.18
6.53
1.7
1.3
—
—
—
0
0
54
253
2.18
6.53
1.7
1.3
—
—
—
0
0
38
153
2.52
6.46
2.3
1.8
—
—
—
0
0
35
136
2.61
6.40
4.8
3.8
30.6
25.2
mg/l
0.36
29
107
35
136
2.61
6.40
4.8
3.8
55.0
94.6
mg/l
0.37
29
108
180
1224
1.53
6.31
3.3
2.1
322.7
368.9
nmol/l
3.11
175
1142
40
167
2.43
6.31
3.1
2.3
17.4
17.5
%
0.03
20
84
83
462
1.84
6.23
1.8
1.6
—
—
—
0
0
110
666
1.70
6.20
6.6
3.5
1.2
1.2
mmol/l
2.14
101
570
476
3870
1.34
6.10
4.4
3.3
31.3
30.8
u/l
0.08
457
3699
35
140
2.54
6.05
1.2
1.3
—
—
—
0
0
20
58
3.48
6.02
2.1
1.5
—
—
—
0
0
58
289
2.05
6.01
1.3
1.2
1.8
10.1
u/ml
—
8
48
12
23
5.25
6.01
2.3
2.0
—
—
—
0
0
82
461
1.82
5.97
4.4
5.3
3.1
3.2
g/l
0.60
75
440
1336
12628
1.50
5.94
12.7
8.2
29.0
27.0
u/l
0.60
1308
12248
32
124
2.61
5.90
1.9
2.1
—
—
—
0
0
269
2011
1.41
5.80
3.2
2.7
131.0
100.6
ug/g
0.83
220
1603
98
587
1.72
5.76
2.2
1.7
—
—
—
0
0
336
2613
1.37
5.71
2.8
2.2
—
—
—
0
0
52
254
2.08
5.70
1.7
1.6
—
—
—
0
0
73
404
1.85
5.60
6.0
5.6
0.6
0.7
%
0.25
68
392
20
61
3.31
5.59
1.8
1.5
—
—
—
0
0
60
312
1.96
5.55
1.3
1.2
39.0
47.7
u/ml
—
6
18
36
153
2.39
5.50
1.9
1.4
—
—
—
0
0
29
111
2.64
5.49
2.0
1.4
—
—
—
0
0
56
287
1.99
5.41
1.3
1.2
1.5
2.9
u/ml
—
5
34
49
239
2.09
5.41
2.0
1.3
—
—
—
0
0
16
43
3.75
5.37
1.4
1.4
41140.1
26758.5
e6/l
—
9
26
56
289
1.97
5.31
2.7
2.1
1.3
1.3
g/l
0.11
51
255
618
5287
1.29
5.27
4.5
4.0
—
—
—
0
0
419
3415
1.31
5.13
1.8
1.7
96.8
97.9
pmol/l
0.22
223
1877
28
112
2.53
4.89
1.9
1.7
—
—
—
0
0
1035
9497
1.29
4.80
4.3
3.9
14.6
14.4
pmol/l
1.25
959
8808
143
991
1.49
4.61
9.7
7.2
1.1
1.1
mmol/l
0.02
108
703
71
415
1.75
4.60
1.8
1.6
97.1
0.2
iu/ml
—
10
87
49
257
1.94
4.48
1.2
1.2
16.5
22.7
u/ml
—
8
23
177
1287
1.43
4.45
1.7
1.6
1169.4
1136.0
nmol/l
0.22
138
995
23
88
2.64
4.40
4.1
3.3
25.7
27.0
umol/l
0.29
23
88
57
317
1.83
4.37
1.8
1.8
—
—
—
0
0
10
22
4.57
4.30
2.3
1.1
—
—
—
0
0
389
3205
1.29
4.29
2.4
2.2
—
—
—
0
0
144
1015
1.46
4.27
9.8
7.1
5.0
5.1
kpa
0.43
138
960
14
41
3.44
4.19
1.4
1.2
—
—
—
0
0
237
1829
1.35
4.16
1.3
1.2
11.6
9.5
u/ml
0.16
98
743
173
1269
1.41
4.14
5.8
3.3
7.3
6.7
umol/l
0.17
150
1063
422
3527
1.27
4.13
2.5
2.3
—
—
—
0
0
27
116
2.35
4.10
7.6
8.9
9.9
10.1
mg/l
0.09
27
107
61
354
1.75
4.09
2.0
1.9
—
—
—
0
0
243
1892
1.34
4.02
1.7
1.4
20.0
20.5
nmol/l
0.21
215
1653
1188
11181
1.29
4.01
4.3
3.8
—
—
—
0
0
13
38
3.44
3.90
2.0
1.6
—
—
—
0
0
38
193
1.99
3.84
1.2
1.2
—
—
—
0
0
25
107
2.36
3.84
1.8
1.5
—
—
—
0
0
337
2762
1.28
3.83
2.7
2.3
2.7
2.7
mg/l
0.07
297
2402
20
78
2.59
3.72
1.6
1.5
—
—
—
0
0
20
78
2.59
3.72
1.6
1.5
—
—
—
0
0
20
78
2.59
3.72
1.5
1.5
—
—
—
0
0
1090
10187
1.25
3.69
3.5
3.1
1.3
1.2
mmol/l
0.46
1035
9638
8
12
6.69
3.67
2.4
1.0
—
—
—
0
0
1176
11091
1.27
3.67
20.0
13.1
13.4
13.3
%
0.76
1158
10892
65
398
1.66
3.62
1.3
1.1
—
—
—
0
0
12
35
3.45
3.62
2.0
1.6
—
—
—
0
0
40
212
1.91
3.60
3.6
2.1
7.0
7.3
g/l
0.53
32
162
40
212
1.91
3.60
3.6
2.1
—
—
—
0
0
40
212
1.91
3.60
3.6
2.1
3.7
3.7
g/l
0.03
30
152
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
14
46
3.06
3.53
1.4
1.6
—
—
—
0
0
31
153
2.05
3.42
1.4
1.5
—
—
—
0
0
65
405
1.63
3.40
1.3
1.2
—
—
—
0
0
37
196
1.91
3.36
3.7
2.2
3.2
3.2
g/l
0.10
30
156
35
182
1.94
3.35
1.1
1.1
—
—
—
0
0
12
37
3.26
3.34
2.1
1.6
—
—
—
0
0
307
2528
1.27
3.33
1.7
1.7
1.5
1.4
mmol/l
0.55
266
2209
221
1744
1.31
3.33
1.7
1.6
49721097.1
30086006.1
pmol/l
0.15
179
1519
43
240
1.81
3.33
6.8
5.8
23.9
24.4
mmol/l
0.48
38
213
79
521
1.54
3.28
3.3
3.9
95.9
156.2
ng/l
2.01
72
458
242
1942
1.29
3.22
1.4
1.2
26.1
23.9
iu/ml
0.13
80
570
1161
10997
1.24
3.11
5.0
4.4
1.8
2.0
mu/l
0.81
1101
10369
70
455
1.56
3.11
2.0
2.0
34.6
40.7
u/l
2.32
62
420
76
505
1.53
3.06
1.9
2.2
9.4
8.2
ug/l
0.20
60
454
19
80
2.39
3.06
1.5
1.7
61.4
56.1
%
—
10
62
43
247
1.76
3.05
2.0
1.9
1.9
2.9
ug/l
0.23
37
219
97
680
1.46
3.02
3.3
2.3
71.9
77.9
ml/min/173m2
0.49
33
241
138
1032
1.37
2.99
2.2
2.4
45.3
79.3
u/l
0.32
116
868
5
5
10.03
2.98
1.6
1.2
—
—
—
0
0
989
9236
1.20
2.97
4.8
4.2
37.3
37.7
mmol/mol
0.59
929
8741
1131
10706
1.22
2.93
3.9
3.4
4.6
4.7
mmol/l
0.79
1072
10180
19
82
2.33
2.92
1.2
1.7
—
—
—
0
0
27
135
2.02
2.91
1.8
1.4
—
—
—
0
0
684
6187
1.19
2.90
3.8
2.9
93.6
79.4
ug/l
1.22
648
5832
76
512
1.51
2.89
1.5
1.3
—
—
—
0
0
26
129
2.03
2.87
3.8
3.3
2.0
1.4
%
0.15
20
105
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
223
1.77
2.83
7.3
12.0
0.3
0.3
u/ml
0.08
19
113
113
826
1.40
2.82
9.4
10.3
0.4
0.9
mmol/l
0.76
93
648
213
1711
1.29
2.82
2.3
1.9
—
—
—
0
0
9
23
3.93
2.77
1.2
1.0
—
—
—
0
0
432
3761
1.21
2.75
1.5
1.4
2.8
2.1
u/ml
0.28
109
912
17
72
2.38
2.73
1.1
1.1
1635.6
1463.8
miu/ml
0.35
17
72
11
37
2.99
2.69
1.2
1.1
—
28.3
—
0
6
20
92
2.19
2.67
1.3
1.2
110.2
121.3
u/l
0.07
13
64
103
750
1.40
2.64
14.6
15.5
1.2
1.1
inr
0.14
17
125
1084
10256
1.20
2.64
3.9
3.3
5.7
5.6
mmol/l
0.32
1007
9535
44
267
1.67
2.61
2.0
2.4
210.8
294.6
ug/l
0.44
39
244
1121
10646
1.21
2.59
3.8
3.3
1.4
1.4
mmol/l
1.10
1064
10072
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
11
38
2.91
2.58
1.5
1.7
—
—
—
0
0
258
2146
1.24
2.55
2.4
2.0
—
—
—
0
0
1133
10782
1.20
2.50
4.1
3.6
2.8
2.8
mmol/l
0.75
1069
10165
47
294
1.62
2.50
1.2
1.1
—
—
—
0
0
9
26
3.48
2.48
6.0
6.0
—
—
—
0
0
18
82
2.21
2.48
2.3
1.8
13.2
19.5
mg/l
—
5
27
18
82
2.21
2.48
2.7
1.6
31.7
32.3
pg
0.24
18
82
11
39
2.83
2.47
1.2
1.4
827.5
312.8
u/l
0.69
11
39
124
943
1.34
2.45
1.3
1.4
—
—
—
0
0
108
805
1.37
2.43
2.8
3.4
4.8
4.7
pmol/l
0.31
91
727
300
2554
1.22
2.38
4.3
3.3
1.0
1.0
kg/l
0.11
42
390
198
1618
1.26
2.30
3.8
3.2
549.7
600.7
ng/l
0.06
125
987
14
59
2.39
2.29
1.4
1.2
—
1.8
—
0
5
31
178
1.76
2.27
1.6
1.4
—
—
—
0
0
73
516
1.44
2.25
1.3
1.2
—
—
—
0
0
331
2867
1.20
2.19
4.9
3.7
8.2
8.3
mmol/l
0.14
293
2492
34
203
1.69
2.19
1.6
2.3
—
—
—
0
0
109
829
1.34
2.18
2.3
2.3
17.0
24.4
au/ml
—
7
61
15
68
2.22
2.11
2.1
1.5
2.7
6.5
u/l
—
10
31
24
131
1.85
2.08
1.8
1.4
—
—
—
0
0
14
62
2.27
2.08
1.4
1.2
—
40.7
—
0
6
47
309
1.54
2.07
1.5
1.4
325.7
351.0
ug/g
0.35
26
160
23
125
1.85
2.03
2.2
1.6
—
—
—
0
0
156
1260
1.27
2.01
3.0
2.4
7226.6
5115.0
u/l
0.23
62
489
10
38
2.64
2.01
4.5
3.1
110.4
125.4
ug/l
—
10
38
10
38
2.64
2.01
3.0
2.7
—
—
—
0
0
47
312
1.52
2.00
2.6
2.5
593.5
1140.8
e6/l
0.30
37
251
47
312
1.52
2.00
2.6
2.4
3.3
16.1
e6/l
1.12
34
242
14
64
2.20
1.94
1.4
1.3
—
67.3
—
0
10
1442
14174
1.38
1.88
24.0
15.4
6.8
6.8
e9/l
0.76
1418
13787
291
2526
1.19
1.87
1.7
1.5
—
—
—
0
0
227
1927
1.21
1.86
1.7
1.7
1.3
1.4
%
0.94
202
1757
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
1441
14168
1.37
1.82
23.9
15.3
4.6
4.6
e12/l
0.89
1414
13785
119
943
1.28
1.81
4.8
5.0
—
—
—
0
0
1439
14146
1.36
1.81
24.0
15.4
262.4
261.1
e9/l
0.31
1416
13785
28
170
1.66
1.74
1.8
1.7
10857.7
14129.7
e6/l
0.29
20
131
12
54
2.23
1.74
1.3
2.2
14.0
15.6
umol/l
0.28
12
54
22
125
1.77
1.72
1.3
1.3
—
—
—
0
0
1441
14177
1.35
1.72
24.1
15.4
135.9
136.4
g/l
0.62
1429
14028
13
61
2.14
1.71
1.7
1.3
—
—
—
0
0
94
728
1.31
1.71
1.7
1.6
7.9
7.9
u/l
0.00
72
550
21
118
1.79
1.70
1.2
1.4
—
—
—
0
0
21
118
1.79
1.70
1.2
1.4
—
—
—
0
0
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
21
119
1.78
1.66
1.2
1.4
—
—
—
0
0
6
19
3.17
1.66
2.8
3.5
2.4
4.0
mg/l
—
6
19
21
120
1.76
1.62
1.2
1.4
—
—
—
0
0
21
120
1.76
1.62
1.1
1.1
—
—
—
0
0
97
762
1.29
1.60
1.3
1.2
—
39.0
—
0
31
33
215
1.55
1.57
1.4
1.3
2.8
6.4
u/ml
1.03
15
80
28
176
1.60
1.55
1.0
1.1
—
—
—
0
0
15
78
1.93
1.54
1.0
1.2
—
—
—
0
0
8
33
2.43
1.54
1.3
1.1
—
14.1
—
0
7
23
140
1.65
1.45
6.2
3.1
1.4
1.5
mmol/l
0.49
23
134
18
102
1.77
1.45
1.6
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
80
1.88
1.45
1.1
1.2
—
—
—
0
0
11
52
2.12
1.44
1.9
1.2
—
—
—
0
0
20
118
1.70
1.41
1.3
1.1
—
—
—
0
0
32
214
1.51
1.39
1.4
1.3
4.0
5.4
u/ml
0.43
17
97
12
60
2.01
1.38
1.8
1.2
—
—
—
0
0
69
530
1.32
1.38
1.5
1.5
—
—
—
0
0
75
583
1.30
1.37
1.6
1.4
—
—
—
0
0
27
174
1.56
1.37
1.4
1.2
—
—
—
0
0
136
1140
1.21
1.32
1.3
1.2
152.4
144.4
iu/ml
0.06
46
431
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
14
76
1.85
1.30
1.4
1.2
—
—
—
0
0
11
55
2.01
1.27
1.1
1.0
—
—
—
0
0
9
44
2.05
1.27
1.1
1.0
—
—
—
0
0
37
261
1.43
1.25
1.5
1.4
10.1
13.5
u/l
0.56
32
221
8
36
2.23
1.24
1.4
1.3
—
—
—
0
0
9
45
2.01
1.23
1.1
1.0
—
—
—
0
0
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
19
116
1.65
1.21
1.5
1.8
—
—
—
0
0
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
8
37
2.17
1.21
1.4
1.3
—
—
—
0
0
17
101
1.69
1.20
1.2
1.5
10.3
10.2
umol/l
0.02
17
94
6
26
2.31
1.18
1.2
1.0
29.8
34.7
ng/l
—
6
16
6
26
2.31
1.18
1.2
1.0
266.7
257.5
ng/l
—
6
17
16
94
1.71
1.17
1.2
1.5
1.8
1.7
mmol/l
0.00
16
89
106
879
1.22
1.17
1.8
1.8
—
—
—
0
0
18
110
1.64
1.15
1.7
1.1
—
—
—
0
0
5
20
2.50
1.15
1.8
1.8
—
—
—
0
0
118
991
1.21
1.15
2.8
2.2
12.3
12.4
nmol/l
0.02
108
882
12
65
1.85
1.13
2.3
3.8
—
—
—
0
0
5
21
2.39
1.09
1.6
1.2
—
—
—
0
0
8
41
1.96
1.09
1.0
1.1
—
84.4
—
0
11
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
8
41
1.96
1.09
1.0
1.2
—
71.4
—
0
11
20
128
1.57
1.08
1.3
1.4
—
0.6
nmol/l
—
0
5
7
32
2.19
1.08
3.4
1.8
—
—
—
0
0
31
219
1.42
1.07
1.2
1.3
—
—
—
0
0
14
82
1.71
1.05
1.2
1.1
—
—
—
0
0
9
46
1.96
1.03
1.1
1.0
—
—
—
0
0
5
22
2.28
1.03
2.4
2.2
—
—
—
0
0
7
34
2.06
1.03
1.3
1.4
10.3
9.2
ug/l
—
7
34
232
2080
1.14
1.02
5.0
4.3
15.6
18.1
mg/mmol
0.11
167
1388
9
48
1.88
1.00
2.1
1.2
858.3
421.3
u/l
—
9
41
29
206
1.42
0.99
2.9
2.3
133.7
134.2
g/l
0.04
24
157
22
148
1.49
0.98
1.0
1.0
—
—
—
0
0
0
29
0.00
0.97
0.0
1.0
—
4.5
—
0
22
12
69
1.75
0.96
1.2
1.1
379.5
213.0
iu/ml
0.34
12
69
22
149
1.48
0.95
1.2
1.0
—
—
—
0
0
13
77
1.69
0.95
3.6
2.3
107.9
105.7
mmol/l
1.96
13
77
108
919
1.19
0.95
2.2
1.6
335.8
305.5
mu/l
0.37
100
826
14
85
1.65
0.94
1.4
1.2
—
—
—
0
0
9
52
1.74
0.92
2.0
1.6
—
—
—
0
0
13
78
1.67
0.91
3.6
2.2
4.1
4.0
mmol/l
0.93
13
78
14
86
1.63
0.91
1.0
1.0
—
—
—
0
0
17
110
1.55
0.90
1.6
1.1
—
—
—
0
0
18
119
1.52
0.88
1.1
1.4
1.6
1.4
promille
0.17
13
94
8
43
1.86
0.87
1.6
1.1
—
—
—
0
0
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
21
146
1.44
0.82
1.1
1.0
—
—
—
0
0
12
73
1.65
0.81
1.3
1.5
—
—
—
0
0
6
33
1.82
0.79
3.0
2.2
—
—
—
0
0
52
423
1.24
0.75
1.1
1.1
8.5
4.7
u/ml
0.41
19
196
13
83
1.57
0.75
1.4
1.1
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
17
117
1.46
0.72
1.6
1.4
294.8
354.5
pmol/l
0.20
11
91
38
301
1.27
0.69
1.1
1.1
—
—
—
0
0
30
230
1.31
0.69
4.6
3.3
24.0
25.8
mg/l
0.12
21
142
130
1449
0.89
0.64
1.6
1.5
—
—
—
0
0
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
5
29
1.73
0.64
1.0
1.3
—
—
—
0
0
85
740
1.16
0.62
1.4
1.3
248.9
233.7
miu/ml
0.13
38
380
6
105
0.57
0.61
1.2
1.4
—
—
—
0
0
8
50
1.60
0.61
1.1
1.1
20.2
30.4
u/l
—
8
36
8
50
1.60
0.61
1.1
1.1
94.9
96.6
u/l
—
8
38
24
184
1.31
0.58
3.5
3.2
—
—
—
0
0
6
35
1.72
0.57
1.2
1.3
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
28
221
1.27
0.55
1.7
1.2
—
—
—
0
0
186
1716
1.10
0.54
3.5
3.6
1.6
2.0
ug/l
0.91
168
1572
6
38
1.58
0.54
4.0
3.6
—
—
—
0
0
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
34
278
1.23
0.51
4.2
3.4
27.1
22.1
nmol/l
1.08
34
272
31
252
1.23
0.50
1.6
1.6
7.1
7.4
mmol/l
0.40
25
146
32
389
0.82
0.49
1.4
1.6
—
—
—
0
0
107
969
1.11
0.47
3.5
3.3
30.7
31.3
%
0.24
84
719
1257
12420
1.07
0.45
17.6
11.7
40.0
40.4
%
1.13
1050
10429
19
147
1.30
0.45
1.1
1.1
103.9
92.3
%
1.10
19
138
77
862
0.89
0.45
1.5
1.4
—
—
—
0
0
10
69
1.45
0.44
1.4
1.2
—
—
—
0
0
77
861
0.89
0.44
1.5
1.4
—
—
—
0
0
77
860
0.89
0.43
1.4
1.4
—
—
—
0
0
5
31
1.61
0.43
1.8
1.8
—
17.6
—
0
12
10
70
1.43
0.41
1.5
1.8
—
—
—
0
0
77
857
0.89
0.41
1.5
1.4
—
—
—
0
0
16
123
1.30
0.40
1.8
5.5
7.4
6.6
mmol/l
0.43
16
101
0
19
0.00
0.39
0.0
1.2
—
0.4
—
0
13
9
66
1.37
0.38
1.9
3.7
—
—
—
0
0
9
66
1.37
0.38
1.9
3.7
—
—
—
0
0
59
525
1.13
0.37
1.3
1.4
—
—
—
0
0
38
439
0.86
0.36
1.6
1.3
—
—
—
0
0
101
1093
0.92
0.34
1.4
1.4
—
—
—
0
0
27
229
1.18
0.32
1.1
1.1
—
—
—
0
0
87
945
0.92
0.32
1.5
1.5
—
—
—
0
0
101
937
1.08
0.31
1.6
1.5
20.5
17.3
iu/l
0.45
85
742
63
573
1.10
0.29
3.8
4.3
13.8
15.2
ug/l
0.04
46
438
14
112
1.25
0.28
1.1
1.3
118.0
51.3
pmol/l
—
5
33
159
1674
0.94
0.27
1.5
1.5
—
—
—
0
0
39
347
1.13
0.27
1.7
2.0
4.0
5.2
iu/l
0.42
13
135
8
66
1.21
0.26
1.9
1.5
—
67.4
%
—
0
9
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
43
388
1.11
0.24
1.1
1.1
5.7
6.2
u/ml
0.06
22
194
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
32
355
0.90
0.20
1.7
1.9
—
—
—
0
0
6
48
1.25
0.20
1.2
1.0
47.9
46.7
u/ml
—
6
48
61
652
0.93
0.18
1.4
1.5
—
—
—
0
0
53
493
1.08
0.18
1.7
1.6
—
—
—
0
0
19
166
1.15
0.18
2.5
1.7
—
—
—
0
0
7
61
1.15
0.17
1.6
1.2
—
—
—
0
0
40
368
1.09
0.17
1.1
1.1
0.3
0.4
u/ml
0.57
13
123
65
611
1.07
0.17
1.2
1.2
0.5
2.5
u/ml
3.36
30
316
19
167
1.14
0.17
3.4
2.6
35.8
152.0
ug/min
1.56
12
108
24
267
0.90
0.16
1.0
1.0
1.4
3.1
u/ml
—
7
128
6
79
0.76
0.15
1.2
1.2
0.9
5.7
u/ml
—
6
68
68
717
0.95
0.15
1.6
2.0
—
—
—
0
0
9
83
1.08
0.14
4.0
2.1
—
—
—
0
0
32
297
1.08
0.12
1.6
1.4
71.0
121.4
pmol/l
0.62
32
286
38
404
0.94
0.11
1.2
1.2
—
—
—
0
0
39
414
0.94
0.11
1.4
1.3
3.3
3.6
ug/l
0.23
32
389
33
309
1.07
0.10
1.4
1.4
0.3
0.4
nmol/l
0.11
26
262
27
252
1.07
0.09
1.3
1.1
6.0
1736.2
iu/ml
—
10
78
24
223
1.08
0.09
1.2
1.5
—
—
—
0
0
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
5
62
0.81
0.08
1.4
1.2
—
—
—
0
0
60
622
0.96
0.08
1.6
1.6
5.9
3.7
mg/l
0.36
49
421
53
550
0.96
0.07
1.3
1.1
6.9
2.7
u/ml
0.43
15
174
72
742
0.97
0.07
1.8
1.7
—
—
—
0
0
137
1343
1.02
0.07
3.4
3.3
22.5
21.3
%
0.40
47
465
14
129
1.09
0.05
1.2
1.1
—
—
—
0
0
83
812
1.02
0.05
1.5
1.5
—
—
—
0
0
109
1073
1.02
0.04
1.0
1.1
—
—
—
0
0
13
121
1.08
0.03
13.9
11.9
0.5
0.6
mmol/l
1.25
13
111
14
131
1.07
0.03
1.6
1.6
—
—
—
0
0
101
998
1.01
0.02
2.6
2.4
0.6
0.7
ug/l
0.76
53
512
39
397
0.98
0.01
5.2
2.6
7.7
6.6
umol/l
0.35
31
311
12
116
1.03
0.00
1.2
1.3
0.5
22.9
u/ml
—
7
92
0
5
0.00
0.00
0.0
1.2
—
30.8
—
0
5
5
54
0.93
0.00
1.0
1.1
—
7.6
—
0
29
5
54
0.93
0.00
1.0
1.1
—
3.2
—
0
29
0
6
0.00
0.00
0.0
1.3
—
5.5
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
0.00
1.0
1.0
175.0
164.5
g/l
—
5
57
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_SKIN_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_SKIN_NOS | 1.294 [0.99, 1.68] | 0.055 |
| Birth year | 0.991 [0.98, 1.0] | 0.042 |
During the follow-up period (1.1.1998 — 31.12.2019), 151 out of 9236 females with AB1_VIRAL_SKIN_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_SKIN_NOS | 1.53 [1.19, 1.97] | 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 183 out of 9318 males with AB1_VIRAL_SKIN_NOS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_SKIN_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.102% | 0.274% |
| 5 | 0.692% | 1.95% |
| 10 | 1.648% | 4.642% |
| 15 | 3.33% | 8.646% |
| 20 | 5.563% | 14.317% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_SKIN_NOS – Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data